Arrowhead Invests $1M in Calando Subsidiary

The companies also converted roughly $8 million in Calando debt it owed Arrowhead into equity.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.